Utah Medical Products (UTMD) Cash from Operations (2010 - 2026)

Utah Medical Products' Cash from Operations history runs 17 years deep, the most recent figure standing at 3109000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 30.35% year-over-year to 3109000.0 in Q1 2026; TTM through Mar 2026 was 13337000.0, a 4.86% decrease from a year earlier, with the FY2025 full-year figure at 14692000.0, down 0.94% from the prior year.
• Cash from Operations declined to 3109000.0 in Q1 2026 per UTMD's latest filing, from 3477000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 6915000.0 in Q1 2023 and bottomed at 2762000.0 in Q2 2024.
• The 5-year median for Cash from Operations is 4832000.0 (2022), against an average of 4474117.65.
• Across the five-year window, Cash from Operations surged 37.04% in 2023 and plunged 44.92% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 5680000.0 in 2022, then slipped by 6.13% to 5332000.0 in 2023, then plunged by 44.92% to 2937000.0 in 2024, then advanced by 18.39% to 3477000.0 in 2025, then dropped by 10.58% to 3109000.0 in 2026.
• Per Business Quant, the three latest UTMD Cash from Operations figures stand at 3109000.0 (Q1 2026), 3477000.0 (Q4 2025), and 3878000.0 (Q3 2025).